Presentation: Accelerated Market Authorization (MAA) Procedures in China

Reviewed Topics:

  • Types of Accelerated Procedures in China
  • Breakthrough Therapy Drug
  • Conditional Approval Procedure
  • Priority Review and Approval Procedure
  • Special Review and Approval Procedure
  • Eligibility criteria
  • Eligibility requirements

ABOUT GLOBAL REGULATORY PARTNERS INC.

Global Regulatory Partners Inc, (GRP) is an American company that provides regulatory affairs, clinical, quality and safety services to medical devices and pharmaceutical companies globally. GRP headquarters is located in Massachusetts USA and its main affiliates are located in China, Japan, Brazil, Mexico and Argentina. GRP helps many life science companies register their products in different countries in compliance with local regulations.

More Resources:

https://globalregulatorypartners.com/countries/asia/china-national-national-medical-products-administration-nmpa/

Follow us on Social Media !

Remain updated on global regulatory content and news